Stryker Corporation (SYK) : Renaissance Investment Group reduced its stake in Stryker Corporation by 1.68% during the most recent quarter end. The investment management company now holds a total of 2,745 shares of Stryker Corporation which is valued at $297,887 after selling 47 shares in Stryker Corporation according to a report filed by the company on Apr 1, 2016 with the SEC.Stryker Corporation makes up approximately 0.15% of Renaissance Investment Group’s portfolio.
Other Hedge Funds, Including , Beacon Financial Group reduced its stake in SYK by selling 15 shares or 0.44% in the most recent quarter. The Hedge Fund company now holds 3,381 shares of SYK which is valued at $366,906. Stryker Corporation makes up approx 0.08% of Beacon Financial Group’s portfolio.
On the company’s financial health, Stryker Corporation reported $1.56 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Jan 26, 2016. Analyst had a consensus of $1.55. The company had revenue of $2715.00 million for the quarter, compared to analysts expectations of $2714.84 million. The company’s revenue was up 3.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.44 EPS.
Many Wall Street Analysts have commented on Stryker Corporation. Barclays Resumed Stryker Corporation on Apr 11, 2016 to “Underweight”, Price Target of the shares are set at $107.Stryker Corporation was Initiated by Nomura to “Neutral” on Mar 17, 2016. Company shares were Reiterated by Deutsche Bank on Feb 1, 2016 to “Buy”, Firm has raised the Price Target to $ 113 from a previous price target of $107 .
Stryker Corporation closed down -0.29 points or -0.27% at $108.25 with 19,12,587 shares getting traded on Monday. Post opening the session at $108.49, the shares hit an intraday low of $108.17 and an intraday high of $108.94 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.